Ramorelix
Ramorelix is a luteinizing-hormone-releasing hormone (LHRH) antagonist. Ramorelix can inhibit tumor progression in vivo. Ramorelix can be studied in anti-cancer research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 127932-90-5
- Fòrmula: C74H95ClN16O18
- Peso molecular:1532.10
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 127932-90-5
-
Peso molecular 1532.10
-
Fòrmula C74H95ClN16O18
-
Sequence
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-Ser-Tyr-{d-Ser(2-(aminocarbonyl)hydrazide)}-Leu-Arg-Pro
-
Sequence Shortening
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-SY-{d-Ser(2-(aminocarbonyl)hydrazide)}-LRP
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Stoeckemann, K., & Sandow, J. (1993). Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations. Journal of cancer research and clinical oncology, 119(8), 457-462. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)